Abacus Health Products, Inc. reported earnings results for the third quarter and nine months ended September 30, 2019. For the quarter, revenue was $4,073,928 compared to $2,064,117 a year ago. Net and comprehensive income was $58,584 compared to loss of $102,862 a year ago.

For the nine months, revenue was $11,118,478 compared to $5,579,000 a year ago. Net and comprehensive loss was $12,007,306 compared to income of $1,044,713 a year ago. Loss per share - basic was $0.64.

Based on existing and anticipated purchase orders the company expects fourth quarter 2019 revenue to result in quarterly sequential growth of 20%-25%, and in particular driven by CBDMEDIC in the F/D/M channel.